Mats Sundgren, Scientific advisor of IOMED, proudly participated in the Festival of Biologics held from October 15-17, 2024, in Basel, Switzerland. This event brought together industry leaders, researchers, and innovators from around the globe to discuss advancements in biologics and the future of clinical trials.

Mats delivered a keynote presentation titled "Revolutionizing Clinical Trials through RWD and AI: Unleashing Innovation". During his talk, he highlighted how Real-World Data (RWD) and Artificial Intelligence (AI) are transforming clinical trial methodologies, enabling more efficient and effective research processes.

‍

‍

As a key player in the health data landscape, IOMED emphasizes the importance of utilizing RWD to enhance decision-making and streamline clinical trial designs. Our commitment to innovation positions us as a strategic partner in advancing clinical research and improving patient outcomes. We extend our gratitude to the Festival of Biologics organizers for this incredible opportunity and to everyone who contributed to the success of the event. Together, we are advancing the future of biologics through collaboration and innovation.